Today
-1.77%
5 Days
+0.07%
1 Month
+3.53%
6 Months
+18.92%
Year to Date
+28.35%
1 Year
+44.84%
Unitedhealth Group Inc's fundamentals are relatively healthy, and its growth potential is significant.Its valuation is considered fairly valued, ranking 48 out of 75 in the Healthcare Providers & Services industry.Institutional ownership is very high.Over the past month, multiple analysts have rated it as Buy, with the highest price target at 471.24.In the medium term, the stock price is expected to trend up.The company has shown average stock market performance over the past month, with weak fundamentals and technicals.The stock price is trading sideways between the support and resistance levels, making it suitable for range-bound swing trading.
Media Coverage
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
TradingKey - UnitedHealth beat Q2 2026 EPS by 30%, reported an 86.7% medical cost ratio (down from 89.4%), and raised full-year guidance to $19.50 to $20.00 per share. At $425 in a rising channel, here’s what $454 needs and why the DOJ investigation still matters.
TradingKey — This month, approximately 6 million people across the U.S. will begin receiving settlement payments averaging about $333 per person. The funds originate from a $2.67 billion antitrust class-action settlement involving the Blue Cross Blue Shield Association (BCBS), following more than a
UNH beat Q1 EPS by 10% at $7.23, MCR improved to 83.9%, and guidance raised to >$18.25. Stock jumped 8%. Key breakout level $357, targets $380–$407. Buy or wait?
TradingKey - Defensives run on resilience: predictable demand, strong cash flow, conservative balance sheets, and tame volatility. You can’t just look at a sector name to find them. It requires a systematic examination of cash generation, leverage, dividend sustainability, beta, competitive moats, a
UnitedHealth Group Stock Analysis: Why has UNH's stock price halved this year? Should investors follow Buffett's lead and continue holding? Will UNH's stock price hit new lows?
TradingKey - As US tech stocks grapple with AI bubble concerns and faltering performance, quarterly 13F filings from investment institutions are entering a heavy disclosure period. These reports will unveil "smart money" strategies and could influence future market direction. However, given recent
UnitedHealth Group Incorporated is an American multinational for-profit organization that specializes in health insurance and healthcare services, located in Eden Prairie, Minnesota. Operating under the UnitedHealthcare brand for insurance products and the Optum brand for healthcare services, it is recognized as the world's seventh-largest company by revenue and the largest healthcare corporation by revenue. The company ranks 8th on the 2024 Fortune Global 500 list, with a market capitalization of $460.3 billion as of December 20, 2024. UnitedHealth Group has encountered numerous investigations, lawsuits, and penalties—including SEC enforcement related to stock option backdating, Medicare overbilling, unfair claims practices, denials of mental health treatments, and anticompetitive conduct—illuminating deep-rooted issues of fraud, patient harm, and corporate misconduct.
Related Instruments
Popular Instruments
